Nazha-led Team Designs Personalized Prediction Model for Patients with MDS
Patients with myelodysplastic syndromes (MDS)
not only face mortality risk, but the risk that their disease transforms to a more aggressive bone marrow cancer,
acute myeloid leukemia (AML).
At the American Society of Hematology (ASH) Annual Meeting earlier this month, Cleveland Clinic hematologist and oncologist Aziz Nazha, MD
presented a personalized prediction model for patients with MDS that surpassed current prediction models, according to a recent press release.
Dr. Nazha and his colleagues developed a model that incorporates individual patient genomic and clinical data using a machine-learning algorithm to better predict survival probabilities and outcomes. Next, the team will create a website where clinicians can input patient clinical and genetic characteristics to receive probability of surviving various periods of time. Dr. Nazha is a member of the Case CCC's Hematopoietic and Immune Cancer Biology program. more>
Barnholtz-Sloan Featured as Leader in Brain Tumor Statistics and Brain Tumor Epidemiology
In celebrating 45 years of pursuing their mission
to improve, extend, and ultimately save lives of those affected by a brain tumor diagnosis, the American Brain Tumor Association is profiling 45 individuals that have contributed to that mission. Among those featured is Jill Barnholtz-Sloan, PhD, associate director for bioinformatics at the Case Comprehensive Cancer Center.
Enhance Your CV: Bench-to-Bedside Retreat Seeks Planning Committee Members
The Office of Cancer Training, Education, and Research (OCTER) of the Case Comprehensive Cancer Center is excited to announce a new opportunity to design, develop and implement a cancer-focused bench-to-bedside retreat. OCTER is looking for graduate and medical students, post-docs, residents and fellows with an interest in cancer research to join the retreat planning committee and help spearhead this effort. more>
Cancer Center Seminar Series: "On prediction in complex systems"
Dec 14, 12p | WRB Auditorium
Friday, December 14
at 12p in the WRB Auditorium to hear
Eben Rosenthal, MD
present "Enhanced surgical margin detection -'Light up my tumor'.
This seminar is presented by the Cancer Imaging Program.
Eben Rosenthal serves as the Ann and John Doerr Medical Director of the Stanford Cancer Center.
He oversees the clinical delivery of cancer care across Stanford Medicine and its cancer networks. He
is clinically active in microvascular reconstruction of complex head and neck defects. As a surgeon-
scientist, he conducts early phase clinical trials for diagnostic and therapeutic agents for the treatment
of solid tumors. He leads a multidisciplinary team that performs first in human clinical trials using
fluorescently labeled antibodies as a cancer specific contrast agent for use in the operating room.
Cancer Center Seminar Series Winter Break
Case Western Reserve University and the Case Comprehensive Cancer Center will be closed Monday December 24, 2018 through January 1, 2019 for Winter break. The Cancer Center Seminar Series will resume Friday, January 11, 2019.
Click here for a list of upcoming seminars.
CME Courses available through Cleveland Clinic
Get a head start on your CME credits early in 2019 with the following events:
January 23, 2019
February 13, 2019
3rd Annual Cancer Disparities Symposium
Mar 1, 2019 | Tinkham Veale University Center
Will you be one of our presenters?
Deadline for Abstract Submission
The deadline to submit abstracts for this symposium is fast approaching! Abstracts are due
via email (
Friday, December 21
at 5pm EST.
Office of Cancer Disparities Research at the Case Comprehensive Cancer Center
invites multidisciplinary researchers, community agencies and organizations to submit abstracts for presentation at the 3rd Annual Cancer Disparities Symposium. Abstracts will be divided into two tracks:
. Meritorious abstracts will be selected for oral presentations.
**Students who submit an abstract are able to register for FREE! Submit your abstract to
BEFORE registering. You will be emailed a discount code to be entered on the registration form so that you receive the discount.
Registration is OPEN for this symposium.
Click here for registration information.
2019 Symposium Highlights
- Eliseo J. Pérez-Stable, MD, Director, National Institute on Minority Health and Health Disparities (NIMHD), National Institutes of Health (NIH), will discuss cancer disparities research trends and funding opportunities.
- Rick Kittles, PhD, Associate Director of Health Equities at City of Hope, will give a research-focused presentation on cancer disparities research.
- An entire afternoon session is devoted to research aligned with abstract submissions; this includes oral presentations from selected abstracts, plus a poster session. Students who submit an abstract can attend this symposium free of charge.
- The audience for this symposium is diverse in background and field, allowing attendees to interact, network, and expand their knowledge and opportunities for collaboration.
|Sarcoma SPORE Career Development Program
LOI Deadline: Jan 7, 2019
Proposal Deadline: Mar 25, 2019
The Sarcoma Alliance for Research Through Collaboration (SARC) Sarcoma SPORE Career Development program was initiated to support the ideas and work of investigators that complement the depth of sarcoma translational research and to help ensure the continual renewal of high-quality scientific endeavors in the SARC Sarcoma SPORE.
|ASH Research Training Award for Fellows
Deadline: Jan 15, 2019
The American Society of Hematology (ASH) Research Training Award for Fellows (RTAF) is designed to encourage junior researchers in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology. The RTAF awards fellows in training so they will have protected time for research and is to be used primarily for salary support for the applicant.
|Bladder Cancer Research Innovation Award
LOI Deadline: Jan 16, 2019
The Bladder Cancer Advocacy Network (BCAN) is pleased to announce the 2019 Bladder Cancer Research Innovation Award to support the work of one investigator with an exceptionally novel and creative project with great potential to produce breakthroughs in our understanding of the management of bladder cancer. One proposal will be funded for $300,000 over two years ($150,000 per year).
|SFA Research Grants
Deadline: Jan 31, 2019
The Sarcoma Foundation of America (SFA)
h as developed a program to provide grants to investigators interested
translational science sarcoma research. Funding is available to cover equipment and supplies
research on the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas.
Medwire News - Nov 26, 2018
A recent study co-authored by Cleveland Clinic oncologist and
Case CCC member
Nathan Pennell, MD, PhD was highlighted for a promising disease-free survival rate of 88% at two years.
Dr. Dean Discusses Ongoing Research on Biomarkers in MCL
OncLive - Nov 27, 2018
Robert Dean, MD of Cleveland Clinic is featured in this OncLive TV video noting, "There's a high degree of genomic instability in mantle cell lymphoma," as he elaborates on the biology of the disease. Dr. Dean is a member of the Hematopoietic and Immune Cancer Biology Program at the Case CCC.
Prevention - Dec 6, 2018
CWRU have discovered how to train computers to quickly and accurately predict which lung cancer patients will benefit from chemotherapy and which may be able to avoid the intense treatment. "Clinicians don't have a good way of deciphering this right now, and it's an easy way to look at biopsies that have already been collected to give patients more accurate diagnoses and treatment plans," says
Anant Madabhushi, PhD. Dr. Madabhushi is director of the Center for Computational Imaging and Personalized Diagnostics in the Case School of Engineering and member of the
Case CCC Cancer Imaging Program.
NIH BULLETIN - Notices and Funding Opportunities
Have news or updates to share?
Contact Gillian Irwin at
Fri, Dec 14
Cancer Center Seminar Series Guest Speaker
Eben Rosenthal, MD Associate Director of Clinical Care, Stanford Cancer Institute
Medical Director, Stanford Cancer Center
"Enhanced surgical margin detection - 'Light up my tumor' "
12p WRB Auditorium
Mon, Dec 17
Cancer Center Research Chalk Talk
1p WRB 3-136
Tues, Dec 18
Radiation Oncology Grand Rounds
Mamta Singh, Phd
Physicist IV, Associate Professor, Curricular Affairs, CWRU
"Health Systems Science 101"
8:10a Lerner Tower B-151
Cancer Impact Lecture
Janna Kiselar, PhD
Assistant Director, Center for Proteomics and Bioinformatics, CWRU
Cancer Drug Discovery and Resistance
Clark Distelhorst, MD, PhD
Professor, Hematology and Oncology, CWRU/UH
3p WRB 1-422D
Thurs, Dec 20
Developmental Therapeutics Journal Club
Molecular Biology and Microbiology Seminar
Marie McCausland and Braulio Llorens
Levine lab, CWRU
Fri, Dec 21
Taussig Cancer Institute Grand Rounds
Mon, Dec 24 - Mon, Jan 1
Case Western Reserve University and Case Comprehensive Cancer Center Closed for Winter Break
ADDITIONAL UPCOMING SYMPOSIUMS & EVENTS
3rd Annual Cancer Disparities Symposium
Mar 1, 2019
7:30a-4p Tinkham Veale University Center
44th Annual ONS Congress
April 11-14, 2019
Dialogue for Action® on Cancer Screening and Prevention
April 24-26, 2019
GvHD National Symposium
Apr 26, 2019
Cleveland Airport Marriott
Apr 27-28, 2019
2019 Great Lakes Breast Cancer Research Symposium
May 2, 2019
PREVIOUSLY ANNOUNCED OPPORTUNITIES
External Deadline: Jan 22, 2019
LOI Deadline: Jan 22, 2019
Proposal Deadline: Feb 22, 2019
Deadline: Feb 1, 2019
Deadline: April 15, 2019